Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 37 holding rows worth $1,752,422,000.

Accession
0001166309-17-000006
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 37 entries on the cover page, a total value of $1,752,422,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,752,424,000 with VALUE read as thousands by filing date, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MEDICINES CO584688105COM2,461,240$93,552,000thousands by filing date
POST HLDGS INC737446104COM1,172,466$91,042,000thousands by filing date
GODADDY INC CL A380237107Stock2,036,589$86,392,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM1,336,479$83,757,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO468,130$77,368,000thousands by filing date
SOMNIGROUP INTERNATIONAL INC COM88023U101Stock1,235,543$65,966,000thousands by filing date
Gilead Sciences,Inc.375558103COM921,797$65,245,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock759,127$60,548,000thousands by filing date
ARMSTRONG WORLD INDS INC NEW04247X102COM1,251,456$57,567,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW371,361$57,242,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM2,811,092$54,957,000thousands by filing date
ALLERGAN PLCG0177J108SHS222,896$54,184,000thousands by filing date
Morgan Stanley617446448COM1,210,359$53,934,000thousands by filing date
ELDORADO RESORTS INC28470R102COM2,695,132$53,903,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS1,915,076$52,645,000thousands by filing date
AETNA INC NEW00817Y108COM344,409$52,292,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock403,158$51,765,000thousands by filing date
HUMANA INC COM444859102Stock214,336$51,574,000thousands by filing date
Merck & Co.,Inc.58933Y105COM791,899$50,753,000thousands by filing date
META PLATFORMS INC CL A30303M102COM321,505$48,541,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock4,645,265$46,685,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM138,087$46,515,000thousands by filing date
INCYTE CORP COM45337C102Stock368,034$46,339,000thousands by filing date
VERISIGN INC COM92343E102Stock397,036$36,908,000thousands by filing date
ADIENT PLCG0084W101ORD SHS527,133$34,464,000thousands by filing date
LIBERTY BROADBAND A530307107COMMON STOCK390,292$33,483,000thousands by filing date
MGM RESORTS INTERNATIONAL552953101COM1,037,935$32,477,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM405,491$28,052,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock51,505$25,296,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM206,006$25,065,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR750,000$24,915,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM1,341,143$21,592,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,135,280$21,434,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock1,524,191$21,339,000thousands by filing date
PRETIUM RESOURCES INC74139C102COMMON STOCK-FO1,651,328$15,869,000thousands by filing date
MGM GROWTH PPTYS LLC55303A105CL A COM500,000$14,595,000thousands by filing date
CHIPOTLEMEXICANGRILLI169656105STOK34,053$14,169,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-17-000006this filing2017-08-14acceptance time not in the bulk data set